Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.35−0.03 (-7.03%)
Close on Nov 18, 2026Market cap $1.83MP/E –Yield –
Jaguar Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Jaguar Health's revenue for the twelve months ending Jun 30, 2026 was $27.82M, up 135.5% year over year. For fiscal 2025 it was $11.51M, down 1.5% from the year before. Over ten years it grew 46.2% a year on average. The highest annual figure on record is $11.96M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.51M | -1.5% |
| FY2024 | Dec 31, 2024 | $11.69M | +19.8% |
| FY2023 | Dec 31, 2023 | $9.76M | -18.4% |
| FY2022 | Dec 31, 2022 | $11.96M | +175.8% |
| FY2021 | Dec 31, 2021 | $4.34M | -53.8% |
| FY2020 | Dec 31, 2020 | $9.39M | +62.5% |
| FY2019 | Dec 31, 2019 | $5.78M | +30.8% |
| FY2018 | Dec 31, 2018 | $4.42M | +1.3% |
| FY2017 | Dec 31, 2017 | $4.36M | +2981.6% |
| FY2016 | Dec 31, 2016 | $141.52K | -45.2% |
| FY2015 | Dec 31, 2015 | $258.38K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.23M | -58.9% |
| Q1 FY2026 | Mar 31, 2026 | $20.27M | +815.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.24M | -7.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.08M | -0.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.98M | +9.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.21M | -5.8% |
| Q4 FY2024 | Dec 31, 2024 | $3.51M | +52.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.11M | +10.5% |
| Q2 FY2024 | Jun 30, 2024 | $2.72M | +5.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.35M | -15.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.30M | -27.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.81M | +223.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.58M | +70.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.77M | +185.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.17M | +85.6% |
| Q1 FY2020 | Mar 31, 2020 | $869.00K | -45.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.51M | -5.6% |
| Q3 FY2019 | Sep 30, 2019 | $973.00K | -14.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.71M | +10.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.59M | +44.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.60M | +78.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.13M | +37.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.54M | +5240.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.10M | +2084.8% |
| Q2 FY2017 | Jun 30, 2017 | $896.52K | +3613.4% |
| Q1 FY2017 | Mar 31, 2017 | $822.41K | – |
| Q4 FY2016 | Dec 31, 2016 | $28.88K | – |
| Q3 FY2016 | Sep 30, 2016 | $50.36K | – |
| Q2 FY2016 | Jun 30, 2016 | $24.14K | – |
See a number that looks wrong?